The R882H DNMT3A Mutation Associated With AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers

Cancer Cell - United States
doi 10.1016/j.ccr.2014.02.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dominating the Negative: How DNMT3A Mutations Contribute to AML Pathogenesis

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2017English

DNMT3A Mutation Is Associated With Increased Age and Adverse Outcome in Adult T-Acute Lymphoblastic Leukemia

Haematologica
Hematology
2019English

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

Dnmt3a Deletion Cooperates With the Flt3/Itd Mutation to Drive Leukemogenesis in a Murine Model

Oncotarget
Oncology
2016English

Cranial Irradiation Inhibits Hippocampal Neurogenesis via DNMT1 and DNMT3A

Oncology Letters
Cancer ResearchOncology
2017English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

DNMT3a Methylation in Neuropathic Pain

Journal of Pain Research
AnesthesiologyPain Medicine
2017English

MicroRNA-29a Inhibits Cardiac Fibrosis in SD Rats by Downregulating the Expression of DNMT3A

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2018English

Rapid Development of Myeloproliferative Neoplasm in Mice With Ptpn11D61Y Mutation and Haploinsufficient for Dnmt3a

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy